drugset / Trial / NCT04982796
Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder
Phase 1/2
Active not recruiting
30 enrolled
Portland VA Research Foundation, Inc
Steven & Alexandra Cohen Foundation · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This is a proof-of-concept randomized clinical trial of psilocybin-enhanced psychotherapy versus treatment-as-usual among individuals being treated for methamphetamine use disorder.
Timeline
- Start
- 2022-07-07
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 25 mg | — |
| Subject | Psilocybin | Other / unclassified | 30 mg | — |